Anne M. Fagan - Concepedia

Author

Anne M. Fagan

Washington University in St. Louis ORCID

Also Known As

A Fagan, A M Fagan, A. FAGAN, A. Fagan, A. M. Fagan, A.M. Fagan, ANNE M. FAGAN, Alison Goate, Alzheimer's Disease Neuroimaging Initiative (ADNI), Ana Kim

723

Publications

63.4K

Citations

122

H-Index

156

Concepts

All Affiliations

Washington University in St. Louis Hope Center for Neurological Disorders Massachusetts General Hospital Harvard University German Center for Neurodegenerative Diseases

About

Anne M. Fagan is an author at Washington University in St. Louis specializing in medicine, neuroscience, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	53	74	13.1K
2	Health Sciences	17	19	1.8K
3	Engineering	3	3	222
4	Natural Sciences	2	2	400
5	Public Health	2	2	72

Anne M. Fagan

282

Publications

53K

Citations

108

H-Index

Page 1

	Year	Citations
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Reisa A. Sperling, Paul Aisen, Laurel Beckett, Alzheimer s & Dementia	2011	7K
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease Randall J. Bateman, Chengjie Xiong, Tammie L.S. Benzinger, New England Journal of Medicine	2012	3.7K
Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction Daniel A. Nation, Melanie D. Sweeney, Axel Montagne, Nature Medicine Neuroimaging BiomarkersNeuropsychologyHuman Cognitive DysfunctionBlood–brain BarrierNeurophysiology	2019	1.6K
Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ <sub>42</sub> in humans Anne M. Fagan, Mark A. Mintun, Robert H. Mach, Annals of Neurology	2005	1.2K
APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline Axel Montagne, Daniel A. Nation, Abhay P. Sagare, Nature Neurodegenerative DiseasesMedicineBrain HealthNeurochemical BiomarkersNeurology	2020	1.2K
Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance Joseph M. Castellano, Jungsu Kim, Floy R. Stewart, Science Translational Medicine	2011	1.2K
Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease David M. Holtzman, Kelly R. Bales, Tanya Tenkova, Proceedings of the National Academy of Sciences	2000	931
Cerebrospinal Fluid tau/β-Amyloid42 Ratio as a Prediction of Cognitive Decline in Nondemented Older Adults Anne M. Fagan, Catherine M. Roe, Chengjie Xiong, Archives of Neurology	2007	897
High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis Suzanne E. Schindler, James G. Bollinger, Vitaliy Ovod, Neurology	2019	851
<i>APOE</i> predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal aging John C. Morris, Catherine M. Roe, Chengjie Xiong, Annals of Neurology	2009	820

Page 1